Product NDC: | 0904-3854 |
Proprietary Name: | CARBAMAZEPINE |
Non Proprietary Name: | CARBAMAZEPINE |
Active Ingredient(s): | 100 mg/1 & nbsp; CARBAMAZEPINE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, CHEWABLE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0904-3854 |
Labeler Name: | Major Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075712 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100322 |
Package NDC: | 0904-3854-61 |
Package Description: | 100 TABLET, CHEWABLE in 1 BOX, UNIT-DOSE (0904-3854-61) |
NDC Code | 0904-3854-61 |
Proprietary Name | CARBAMAZEPINE |
Package Description | 100 TABLET, CHEWABLE in 1 BOX, UNIT-DOSE (0904-3854-61) |
Product NDC | 0904-3854 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CARBAMAZEPINE |
Dosage Form Name | TABLET, CHEWABLE |
Route Name | ORAL |
Start Marketing Date | 20100322 |
Marketing Category Name | ANDA |
Labeler Name | Major Pharmaceuticals |
Substance Name | CARBAMAZEPINE |
Strength Number | 100 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |